McGuireWoods’ 2026 Healthcare Private Equity and Finance Conference, held April 29-30 in Chicago, brought together industry leaders to discuss the trends, challenges and opportunities influencing today’s healthcare investment landscape. Discussions focused on deal activity, operational strategy and long-term positioning across the healthcare ecosystem.
Investment Landscape: Rational Valuations and Heightened Selectivity:
Private equity participants described a reset in valuations that has improved entry points, particularly in physician practice management and related services. Conviction has strengthened around consumer-driven models, including concierge medicine, direct-to-consumer pathways and condition-specific platforms in areas like fertility, vision and dental. Panelists noted durable demand in niches rooted in science and integrated care, rather than fad-driven longevity plays.
At the same time, caution prevails in overcrowded or low-differentiation segments, such as labor-intensive services facing rate pressure. Investors highlighted opportunities in consolidating fragmented practices where overleveraged aggregators have faltered, allowing better-capitalized sponsors to integrate operations, invest in technology and unlock synergies at more reasonable multiples. Lower middle-market deals drew particular interest for their potential in talent acquisition, technology deployment and operational lift without relying on multiple expansion. A recent example is Kinderhook Industries’ $1.1 billion take-private of Enhabit, a large home health and hospice provider, which underscores continued appetite for assets with predictable, recurring revenue streams.
Lenders echoed this selectivity, noting resilient financing for quality assets but tighter scrutiny on leverage and cash flow durability amid higher-for-longer rates and wage inflation. Subsectors like Home Health & Hospice, Behavioral Health Care and various health-tech services showed momentum, while high-acuity or Medicaid-heavy models faced headwinds.
Operational Excellence and Technology Enablement as Value Drivers:
A recurring emphasis was the shift from aggregation to execution. Sponsors and operators stressed that overleveraged platforms from prior cycles have created openings for disciplined players focused on integration, culture and repeatable value creation. Key levers include talent retention, digital acquisition engines and technology that drives organic growth rather than price increases alone.
AI emerged as a central theme, as speakers widely noted that its most immediate impact lies in back-office functions such as revenue cycle management, prior authorizations, scheduling and compliance. Several speakers described building internal AI teams or leveraging third-party tools to reduce costs, improve lead generation and enhance retention, potentially delivering 200 to 400 basis points of margin expansion. Clinical applications remain limited due to regulatory and liability risks, but logistical tools such as optimized routing for home care and data-driven customer acquisition are gaining traction.
Panelists cautioned that AI is not a panacea and requires thoughtful implementation to avoid compliance pitfalls or headline risks. Success hinges on pairing technology with strong operations. Businesses that harness data for both efficiency and patient experience are best positioned for long-term success.
Policy and Reimbursement Pressures Reshaping State and Provider Dynamics:
Discussions around the federal reconciliation package known as the “Big Beautiful Bill” (HR1) underscored significant fiscal implications for states, particularly expansion states like Illinois and North Carolina. Reduced provider taxes, work requirements and adjustments to state-directed payments are projected to constrain budgets, with pain points emerging for providers and patients starting in 2027. States face difficult choices between absorbing costs, implementing cuts or pursuing creative financing mechanisms.
Rural and safety-net providers may benefit from targeted transformation funds, but broader Medicaid changes could accelerate shifts toward value-based models. Lenders and investors are monitoring these shifts closely, favoring diversified payer mixes and businesses insulated from single-state or heavy Medicaid exposure. Panelists agreed that while policy changes are creating near-term uncertainty, strong demographic tailwinds and persistent cost pressures will continue to support demand for efficient, lower-acuity care delivery.
Strategic Partnerships and Site-of-Care Evolution:
Health systems and operators are deepening collaborations to address access, cost and consumer expectations. Equity-based joint ventures and other ambulatory partnerships offer alignment on economics and incentives, particularly as site-neutral payment policies gain traction. One prominent example is Medicare’s ongoing effort to pay the same rate for the same service regardless of whether it is delivered in a hospital outpatient department or a freestanding ambulatory surgery center (ASC).
This trend is evident in major moves such as Ascension’s multi-billion-dollar acquisition of AMSURG and its large network of ASCs in June 2025. Community Health Systems, Inc. has continued this trend in 2026. In the first part of 2026 alone, its subsidiaries opened de novo centers in Birmingham and Foley, Alabama, and acquired a majority ownership interest in a center in Anchorage, Alaska, increasing its count to 36 affiliated ASCs.
While contractual arrangements remain common, panelists suggested they are often less durable than equity-based partnerships because they lack shared risk and deeper operational integration, limiting effectiveness as reimbursement pressures and market dynamics evolve.
Key success factors for these partnerships include clear governance, cultural alignment and strong execution discipline. Systems are prioritizing scalable structures that preserve physician autonomy while delivering revenue uplifts. International partnerships for facility expansion and strategic lab collaborations for novel diagnostic tests also surfaced as important growth avenues for organizations like Mayo Clinic. Mayo has actively pursued in-country partnerships to support new international facilities and formed strategic lab partnerships where it serves as both a clinical validation partner and go-to-market partner for novel diagnostics.
Challenges persist around clinical control, reimbursement alignment and relationships between academic medical centers and community physicians, but the overarching trend favors ambulatory expansion to relieve hospital capacity and meet patient preferences for convenient, lower-cost settings.
Subsector Opportunities: Home-Based Care, Dental and Beyond:
Home-based care continues to attract attention due to hospital-at-home programs, aging demographics and payer incentives for lower-cost settings. Valuations have moderated into the high single to low double digits, with differentiation driven by organic growth engines, technology adoption and strong clinical outcomes. Recent transactions such as Dovida’s acquisition of A Place At Home and Superior Home Health Care’s purchase of Pulse Home Health & Hospice illustrate this continued interest in scalable, lower-cost care models.
Pediatric private duty nursing and respiratory-focused durable medical equipment stood out in particular for their stability and recurring revenue characteristics. These sub-niches benefit from non-discretionary demand, relatively sticky payer relationships and lower exposure to reimbursement volatility compared with higher-acuity home health services, making them especially attractive in the current environment.
In the dental space, dental support organizations are navigating workforce pressures and reimbursement dynamics while leveraging technology for diagnosis, scheduling and patient engagement. Multi-specialty platforms offer referral synergies, though operational integration remains key. Single-specialty models, particularly in oral surgery and endodontics, benefit from non-discretionary demand but require strong payer relationships.
Looking Ahead: Discipline, Demographics and Durable Models:
The conference underscored a maturing healthcare market where operational rigor, effective use of technology and disciplined capital deployment are increasingly key differentiators. Demographic tailwinds, including aging populations, rising chronic disease burden and evolving consumer expectations, continue to support demand growth, even as policy and reimbursement dynamics introduce near-term uncertainty.
Against this backdrop, investors and operators that emphasize integrated care models, scalable back-office infrastructure and strong physician alignment are likely to outperform. While volatility in regulation and reimbursement persists, capital is expected to favor businesses with durable margins, strong operational execution and clear pathways to value creation through efficiency and care delivery innovation. Those that achieve this balance will be well positioned to find opportunities in this next phase of healthcare delivery.
